Medicine Description clopix-agrel 75mg
Clopix agrel 75 mg 30 tablets is a medication that functions as a platelet aggregation inhibitor. It works by irreversibly binding to the P2Y12 ADP receptor on platelets, which inhibits the activation of the glycoprotein IIb/IIIa complex necessary for platelet aggregation. This action reduces the ability of platelets to clump together, thereby lowering the risk of thrombus formation in arteries. By preventing the formation of clots, Clopix agrel plays a crucial role in the management of patients at risk for cardiovascular events, ensuring smoother blood flow in the circulatory system.
Indications and Uses of Clopix agrel 75 mg 30 tablets
- Prevention of atherothrombotic events in patients with a history of myocardial infarction.
- Prevention of stroke in patients with a history of recent ischemic stroke or transient ischemic attack.
- Management of patients with peripheral arterial disease.
- Post-stenting in patients undergoing percutaneous coronary intervention.
Side Effects of Clopix agrel 75 mg 30 tablets
- Increased risk of bleeding.
- Gastrointestinal disturbances such as nausea and diarrhea.
- Skin reactions including rash or itching.
- Fatigue or general weakness.
- Rarely, thrombotic thrombocytopenic purpura (TTP).
Storage and Handling
Store Clopix agrel at room temperature, away from moisture and heat. Keep out of reach of children. Do not use past the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be monitored for signs of bleeding or bruising. Inform healthcare providers of any other medications being taken to avoid potential interactions. It is essential to adhere to the prescribed treatment plan and not to discontinue use without consulting a physician. Regular follow-ups are advised to monitor cardiovascular health.